I believe Biota is on the cusp of a re rating. With the flu season hitting with a vengeance in the winter, and bird flu being recorded as I type - there is no doubt in my mind - the FDA will start to reassess the BARDA contract
The Centers for Disease Control and Prevention (CDC) is the national public health institute of the United States.
According to the CDC, Tamiflu, zanamivir’s main competitor, is not as effective at treating the influenza viruses as zanamivir, especially in H1N1 seasonal flu. In fact, tests showed 99.6% of the tested strains of seasonal H1N1 flu and 0.5% of 2009 pandemic flu were resistant to Tamiflu, while no flu samples, seasonal or pandemic, showed any resistance to zanamivir.
Add to My Watchlist
What is My Watchlist?